about
Research as a Standard of Care in the PICU.Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.Update on pediatric sepsis: a review.Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults.Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children.Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children.Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis.Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shockThe temporal version of the pediatric sepsis biomarker risk model.Angiopoietin-1, angiopoietin-2 and bicarbonate as diagnostic biomarkers in children with severe sepsis.Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays.Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.A multibiomarker-based outcome risk stratification model for adult septic shock*.A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology.Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.Pediatric sepsis: challenges and adjunctive therapies.Genome-wide expression profiling in pediatric septic shock.A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsisDevelopment and Validation of a Disease Severity Scoring Model for Pediatric SepsisInterleukin 27 as a sepsis diagnostic biomarker in critically ill adults.Role of biomarkers in sepsis care.Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model.Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model.Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis.Biomarkers for sepsis: a review with special attention to India.Gene expression profiling in sepsis: timing, tissue, and translational considerations.Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatmentBeyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndromeBacteremia in children: epidemiology, clinical diagnosis and antibiotic treatment.Innovation in Pediatric Cardiac Intensive Care: An Exponential Convergence Toward Transformation of Care.Pediatric sepsis.Sepsis in Pediatric Cardiac Intensive Care.Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine?Emerging infection and sepsis biomarkers: will they change current therapies?Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies.Use of biomarkers in pediatric sepsis: literature review.
P2860
Q30278453-1718B4B2-BA70-4716-B894-C09AC282B945Q33434503-63975D71-A9A5-4AC7-BED7-96D533F1950CQ33901670-006BCB30-5D01-4708-8718-E3D9571E617AQ33919446-C32F365C-2AC9-4F25-826D-9D4A987473D5Q34076339-5F25B66A-C007-4EC8-862E-B37C64319B49Q34372114-9A750F95-04C8-4B74-88DD-D6D26722CAB4Q34412569-2B049B05-50D2-4EA1-872F-A8C16102C237Q34424217-B27A47F6-DDF0-42CE-92F6-410BA87F9994Q34490041-6F78254C-99EE-4D39-B305-42FF1D89AE14Q34587242-E9AB4466-5D25-4678-9224-227E3C07D5ABQ35120147-35B3FB4F-26C3-46F4-BD6F-363EB7CD318DQ35276673-A6A9E2D8-2D9D-4399-A10E-F3479C6ADC14Q35660662-A916031B-89C1-4C3D-97D5-61E853C6E1EBQ35672605-662D7351-AAE4-412E-90D8-A85B6C56F136Q36181988-43EA87D1-D06F-48E0-BC2C-4E27D1A07452Q36206033-50E2F757-7A1E-48F5-88C7-3F65DA448DE8Q36341842-0D57402B-6932-465F-AE7A-8E395D0B75F3Q36437648-62264D3B-4529-40A4-B641-825624406B4EQ36689362-6B56783D-7CD2-4013-9BC1-A0AC8A775C60Q36728513-3A729C47-2AC9-419E-91C5-7D1ADCC310EFQ36735992-1B42DB12-B413-42B3-AAD1-3D73151C8379Q36903057-5BCECDB8-17DD-44CD-A0D0-1083F8D60E56Q37165896-FF3E9DB9-305F-4726-BE7D-B302ADF87856Q37239351-0230FB50-1333-449E-8F0F-8D769B29B7DAQ37249625-EE170075-F66D-4E19-8380-2401A63F5F35Q37353938-7A0B3714-8973-4DDA-91A0-17857778913EQ37529311-7D5A4976-4538-4D87-8B28-DBB0EF41F46DQ37625638-0C8FE01B-C7F9-4951-9272-4F681D098447Q37688126-14F6A01D-B26F-4CEE-98F9-02898FC07E81Q38189184-565F5D6C-26A1-44CC-B9F1-25F181D381D1Q38241694-AF0BFEAD-89EE-4BAB-909B-C9E06C57333AQ38277169-71D60370-CA6C-4058-8328-B2FBACF3FBB1Q38542909-72191A2A-53BA-40C4-8BD6-94E9690F47C9Q38607400-8F6EBF72-77B6-41CD-8299-FD8898AC4663Q38777134-98E086C5-8685-4D30-B924-97913D1C15DBQ38834618-BFB86042-5FDE-4A8D-A2F5-730061FD09F6Q38854820-AC0440D9-DDA1-4D64-A99B-E48A3E45D1B0Q38929971-714B36BC-A9FA-49D3-853E-FB068BBA0C17Q38935727-115781A3-9FAF-4646-AE36-C3A41AD265B1Q39093810-5A848584-083C-4803-9E72-0EA0768F8667
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The pediatric sepsis biomarker risk model.
@ast
The pediatric sepsis biomarker risk model.
@en
type
label
The pediatric sepsis biomarker risk model.
@ast
The pediatric sepsis biomarker risk model.
@en
prefLabel
The pediatric sepsis biomarker risk model.
@ast
The pediatric sepsis biomarker risk model.
@en
P2093
P2860
P356
P1433
P1476
The pediatric sepsis biomarker risk model.
@en
P2093
Arun Chopra
Christopher J Lindsell
Eileen Beckman
Geoffrey L Allen
Hector R Wong
Jared W Henricksen
Jeffrey Nowak
Keith Meyer
Kelli Harmon
P2860
P2888
P356
10.1186/CC11652
P577
2012-10-01T00:00:00Z
P5875
P6179
1040789550